Canvax Biotech, Villapharma Research S.L. and Proteros Biostructures Gmbh announce FRIDASTEM, a Eurostars awarded consortium for Drug Discovery and Development targeting Cancer Stem Cells.
FRIDASTEM platform has been established with the aim to accelerate small molecule drug discovery against specific kinases and GPCRs involved in Cancer Stem Cells (CSC) proliferation, migration, invasion or metastasis. CSC are believed to be the cause of resistance to current cancer therapies. The drug discovery of drugs targeting this population of cells within a tumoris therefore of […]
Elier Paz interviewed by Diario Córdoba
In today´s edition, Diario Córdoba publishes an interview with Elier Paz, CEO of Canvax Biotech. During the interview, the journalist Irina Marzo asked about most updated information about the company, currents projects inside Drug discovery and lead molecules. For more information, read the full new here.
Canvax has been awarded with a RETOS-COLABORACIÓN Program funded by MINECO
Canvax Biotech has recently received an endorsement from the Ministry of Economy and Competitiveness (MINECO) through the RETOS-COLABORACIÓN Program. Canvax Biotech will lead the consortium composed by Villapharma Research from Murcia, Instituto de Investigación Biomédica of Bellvitge (IDIBELL), two scientific groups from Instituto de Investigación Biomédica of Córdoba (IMIBIC) and two groups from Universidad de […]
Canvax awarded with a Torres Quevedo contract
Canvax has been recently reinforced its Drug Discovery program by the incorporation of PhD Emilio González González, who was awarded with a Torres Quevedo contract from MINECO (PTQ 2014). He is an experienced scientist-entrepreneur who received his PhD at Complutense University and Centro de Investigaciones Biológicas and received a postdoctoral/biotech education at Stanford University/Transderm and […]
Canvax is awarded with phase I SME instrument H2020
Canvax Biotech’s odour-GPCR-based diagnostics technology is one of the few excellent projects awardees of the highly competitive H2020. For more information, read the attached pdf with all awardees here.
Canvax hosts the annual meeting of the SNC-Integra project
Canvax Biotech has hosted in its headquarters the last Technical Committee of the SNC-Integra project, developed by a biotechnology cluster of Andalusian companies, led by Laboratorios Rovi and where, together with Canvax Biotech,there are participating companies such as VivaCell, Bionaturis, GMV, Vivia Allosterics and Vivia Biotech. This technical committee presented the main conclusions of this […]
Canvax Biotech gets 'Invest in Spain' funds
Canvax Biotech has been a beneficiary of ‘Invest in Spain’ funds from ICEX, that aims to help these companies with foreign participation to develop R&D projects in Spain. The project is based on FRIDA, a cell sensor developed by Canvax, for functional screening of the activity of compounds against the GPCRs to find news drugs […]
Canvax participates in Cenit Oncológica project
The Oncology Consortium, composed of seven Spanish biotech companies and led by PharmaMar, has generated since its launch four years ago, a total of 9 patent applications, 5 papers and 13 posters at international conferences, plus three doctoral theses and 12 scientific publications Together with Canvax and PharmaMar, the other companies involved in the consortium […]